Papers - Tanaka Ryuma
-
The long-term impact of mild COVID-19 on cardiovascular disease and mortality in patients on hemodialysis: a post-Omicron era retrospective observational study
Okamoto, A; Okamoto, T; Ichiyama, T; Fukushima, T; Omizo, S; Asanuma, H; Sato, H; Sakurai, H; Yoneyama, A; Yoneyama, F; Ishii, N; Oishi, T; Tanaka, R; Miura, H; Hamaya, T; Kodama, H; Fujita, N; Murasawa, H; Yamamoto, H; Imai, A; Saitoh, H; Hatakeyama, S; Ohyama, C; Suzuki, T
RENAL FAILURE 47 ( 1 ) 2512053 2025.12
-
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer
Oishi, T; Fujita, N; Kawashima, Y; Shinohara, M; Tabata, R; Yoneyama, F; Tanaka, R; Miura, H; Togashi, K; Okita, K; Horiguchi, H; Tanaka, T; Noro, D; Suzuki, Y; Sato, S; Ohyama, C; Hatakeyama, S
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 2025.9
-
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study
Yoneyama, F; Fujita, N; Kawashima, Y; Shinohara, M; Tabata, R; Tanaka, R; Oishi, T; Miura, H; Togashi, K; Okita, K; Horiguchi, H; Tanaka, T; Noro, D; Suzuki, Y; Sato, S; Ohyama, C; Hatakeyama, S
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 30 ( 9 ) 1858 - 1865 2025.7
-
Annexin A1-Targeted <sc>d</sc>-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate Cancer
Ozaki, K; Yoneyama, T; Kubota, Y; Yoneyama, MS; Nonaka, M; Suzuki, T; Tanaka, R; Ohyama, C; Hatakeyama, S
PROSTATE 85 ( 13 ) 1208 - 1221 2025.7
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study
Yoneyama, F; Shinohara, M; Kawashima, Y; Yoneyama, A; Ishii, N; Oishi, T; Tanaka, R; Miura, H; Kodama, H; Fujita, N; Okamoto, T; Yamamoto, H; Yoneyama, T; Sato, S; Ohyama, C; Hatakeyama, S
INTERNATIONAL JOURNAL OF UROLOGY 32 ( 8 ) 1007 - 1013 2025.5
-
Multicenter, international, retrospective study of prognostic factors for Ra223
Oishi, T; Luo, HL; Hatayama, Y; Kawaguchi, H; Sasaki, D; Tanaka, R; Ishii, N; Mikami, J; Okamoto, T; Yamamoto, H; Aoki, M; Su, YL; Chen, YH; Chang, YH; Chen, YT; Wang, HJ; Ohyama, C; Hatakeyama, S
SCIENTIFIC REPORTS 15 ( 1 ) 10814 2025.3
-
Cross resistance among novel androgen receptor axis-targeted agents in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.
Fujita, N; Yoneyama, F; Kawashima, Y; Tanaka, R; Takuya, O; Miura, H; Okita, K; Ohyama, C; Hatakeyama, S
JOURNAL OF CLINICAL ONCOLOGY 43 ( 5_SUPPL ) 2025.2
-
Real-world treatment patterns and outcomes of novel androgen receptor axis-targeted agents in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.
Fujita, N; Yoneyama, F; Kawashima, Y; Tanaka, R; Oishi, T; Miura, H; Okita, K; Ohyama, C; Hatakeyama, S
JOURNAL OF CLINICAL ONCOLOGY 43 ( 5_SUPPL ) 368 - 368 2025.2
-
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer
Miura, H; Yamamoto, H; Okuyama, Y; Ishi, N; Tanaka, R; Oishi, T; Yoneyama, F; Hamaya, T; Togashi, K; Fujita, N; Okamoto, T; Ohyama, C; Hatakeyama, S
CANCER MEDICINE 13 ( 24 ) e70226 2024.12
-
Trends in the use of local intervention for metastatic hormone-naive prostate cancer: A multicenter retrospective study
Tanaka, R; Hatakeyama, S; Narita, S; Sakurai, T; Tanaka, T; Miura, H; Oishi, T; Kawamura, S; Hoshi, S; Ishidoya, S; Mitsuzuka, K; Ito, A; Tsuchiya, N; Habuchi, T; Ohyama, C
INTERNATIONAL JOURNAL OF UROLOGY 30 ( 11 ) 969 - 976 2023.11
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Ishii, N; Hatakeyama, S; Miura, H; Tanaka, R; Oishi, T; Horiguchi, H; Hosogoe, S; Fujita, N; Iwamura, H; Okamoto, T; Yamamoto, H; Yoneyama, T; Hashimoto, Y; Ohyama, C
INTERNATIONAL JOURNAL OF UROLOGY 30 ( 7 ) 572 - 578 2023.7
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Miura, H; Hatakeyama, S; Tanaka, T; Fujita, N; Horiguchi, H; Tanaka, R; Noro, D; Tokui, N; Okamoto, T; Yamamoto, H; Yoneyama, T; Hashimoto, Y; Ohyama, C
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 41 ( 5 ) E17 - E24 2023.5
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
Oishi, T; Hatakeyama, S; Tabata, R; Fujimori, D; Kawashima, Y; Tanaka, R; Ishii, N; Miura, H; Tanaka, T; Okamoto, T; Yamamoto, H; Yoneyama, T; Hashimoto, Y; Sato, S; Ohyama, C
PROSTATE 83 ( 2 ) 198 - 203 2023.2
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
Ishii, N; Hatakeyama, S; Yoneyama, T; Tanaka, R; Narita, T; Fujita, N; Okamoto, T; Yamamoto, H; Yoneyama, T; Hashimoto, Y; Ohyama, C
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 40 ( 10 ) 451.e1 - 451.e8 2022.10
-
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy
Tanaka, R; Hatakeyama, S; Miura, H; Hamaya, T; Yoneyama, T; Ohyama, C
INTERNATIONAL JOURNAL OF UROLOGY 29 ( 10 ) 1235 - 1237 2022.10
-
Impact of disease status heterogeneity of the STAMPEDE trial arm J population on oncological outcomes in high-risk nonmetastatic prostate cancer
Hatakeyama, S; Tanaka, T; Noro, D; Okamoto, T; Narita, T; Ishi, N; Tanaka, R; Oishi, T; Miura, H; Ohyama, C
EUROPEAN UROLOGY 81 S1718 - S1719 2022.2